A diagnosis of male breast cancer can feel overwhelming, but medical advancements have led to highly effective treatments and ...

Stage 1 mixed cellularity Hodgkin lymphoma is often highly treatable, and many patients achieve long-term remission after frontline therapy. Advances in chemotherapy, radiation techniques and targeted ...

For many people diagnosed with colorectal cancer, surgery can bring lifesaving treatment but also lasting changes.

CURE was live on site at the the 19th Annual New York GU Cancers Congress®, where we spoke with Dr. Ulka Vaishampayan on the ...

A Decision Score provides prognostic discrimination for 10-year locoregional recurrence, with rising score associated with ...

Dr. Anastasia Tousimis explores the feasibility, risks and surgical techniques for performing NSM in radiated patients to ...

An ipsilateral breast cancer recurrence after long disease-free interval may still permit curative-intent local therapy, with ...

Pembrolizumab plus weekly paclitaxel, with investigator-choice bevacizumab, achieved statistically significant PFS and OS improvements, addressing a high unmet need in platinum-resistant ovarian ...

Among patients on q2-week chemotherapy, exercise significantly reduced overall cognitive decline, perceived cognitive impairment, and mental fatigue versus usual care. Attenuated effects with ...

Dr. Ajay K. Nooka, highlights how the evolution of therapy has moved the goalposts from simply achieving remission to pursuing a measurable cure.

In the rapidly shifting landscape of multiple myeloma treatment, the roadmap for a patient diagnosed in 2026 looks vastly different than it did even a decade ago. In a recent interview with CURE, Dr.

explained that getting drugs into the brain is a major hurdle for glioblastoma, as the blood-brain barrier blocks most treatments.